نتایج جستجو برای: ii bcl2

تعداد نتایج: 584067  

Journal: :Blood 2015
Cristina Correia Paula A Schneider Haiming Dai Ahmet Dogan Matthew J Maurer Amy K Church Anne J Novak Andrew L Feldman Xiaosheng Wu Husheng Ding X Wei Meng James R Cerhan Susan L Slager William R Macon Thomas M Habermann Judith E Karp Steven D Gore Neil E Kay Diane F Jelinek Thomas E Witzig Grzegorz S Nowakowski Scott H Kaufmann

Follicular lymphoma (FL), an indolent neoplasm caused by a t(14;18) chromosomal translocation that juxtaposes the BCL2 gene and immunoglobulin locus, has a variable clinical course and frequently undergoes transformation to an aggressive lymphoma. Although BCL2 mutations have been previously described, their relationship to FL progression remains unclear. In this study, we evaluated the frequen...

Journal: :British journal of haematology 2015
Neus Masqué-Soler Monika Szczepanowski Christian W Kohler Sietse M Aukema Inga Nagel Julia Richter Reiner Siebert Rainer Spang Birgit Burkhardt Wolfram Klapper

The differential diagnosis between Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) can be challenging. BL has been reported to express less BCL2 than DLBCL, but this issue has not been analysed systematically. BL expressing BCL2 can be considered to be MYC/BCL2 co-expressors, a feature that is associated with poorer outcome in DLBCL but that has not been correlated with outcome ...

Journal: :Leukemia research 2009
Michael Green Maher K Gandhi Emily Camilleri Paula Marlton Rod Lea Lyn Griffiths

The t(14;18)(q21;q34) BCL2 translocation is a common genetic alteration in follicular and diffuse large B-cell lymphoma. However, it is not invariably associated with BCL2 gene overexpression due to undefined mechanisms that regulate expression from the proximal immunoglobulin heavy-chain (IgH) promoter. The BACH2 transcriptional repressor is able to modulate activity of this promoter. Here we ...

2017
Ki-Tae Hwang Wonshik Han Jongjin Kim Hyeong-Gon Moon Sohee Oh Yun Seon Song Young A Kim Mee Soo Chang Dong-Young Noh

PURPOSE We aimed to reveal the prognostic influence of B-cell CLL/lymphoma 2 (BCL2) on molecular subtypes of breast cancer. METHODS We analyzed 9,468 patients with primary breast cancer. We classified molecular subtypes according to the National Comprehensive Cancer Network (NCCN) and St. Gallen guidelines, mainly on the basis of the expression of hormonal receptor (HR), human epidermal growt...

Journal: :Blood 2003
Xingming Deng Fengqin Gao W Stratford May

Bcl2's antiapoptotic function is regulated by phosphorylation. Bcl2 also regulates cell cycle progression, but the molecular mechanism is unclear. Bcl2 is functionally expressed in mitochondria where it can act as an antioxidant that may regulate intracellular reactive oxygen species (ROS). Since ROS have been reported to act as second messengers in cell signaling, we tested whether Bcl2 phosph...

2011
Russell J. H. Ryan Mai Nitta Darrell Borger Lawrence R. Zukerberg Judith A. Ferry Nancy Lee Harris A. John Iafrate Bradley E. Bernstein Aliyah R. Sohani Long Phi Le

Mutations at codon 641 of EZH2 are recurrent in germinal center B cell lymphomas, and the most common variants lead to altered EZH2 enzymatic activity and enhanced tri-methylation of histone H3 at lysine 27, a repressive chromatin modification. As an initial step toward screening patients for cancer genotype-directed therapy, we developed a screening assay for EZH2 codon 641 mutations amenable ...

2014
Kazem Anvari Mahmoud Reza Kalantari Abdolazim Sedighi Pashaki Mehdi Seilanian Toosi Mohammad Reza Ghavam Hamid Reza Raziee

Background and Objective: Approximately half of patients with diffuse large B-cell lymphoma are cured with current chemotherapy regimens. The purpose of this study was to evaluate Bax and Bcl2 expression and their relationship with the response to chemotherapy. Materials and Methods: This study was a prospective analysis on 44 patients with diffuse large B-cell lymphoma. Their specimens were st...

2016
Jiusheng Deng Dongkyoo Park Mengchang Wang Ajay Nooka Qiaoya Deng Shannon Matulis Jonathan Kaufman Sagar Lonial Lawrence H. Boise Jacques Galipeau Xingming Deng

Multiple myeloma (MM) is a heterogeneous plasma cell malignancy and remains incurable. B-cell lymphoma-2 (BCL2) protein correlates with the survival and the drug resistance of myeloma cells. BH3 mimetics have been developed to disrupt the binding between BCL2 and its pro-apoptotic BCL2 family partners for the treatment of MM, but with limited therapeutic efficacy. We recently identified a small...

Journal: :Blood 1994
M J Dyer V J Zani W Z Lu A O'Byrne S Mould R Chapman J M Heward H Kayano D Jadayel E Matutes

Although translocations of the BCL2 gene are frequent in B-cell non-Hodgkin's lymphomas (B-NHL) the incidence, nature, and prognostic significance of similar translocations in the phenotypically related chronic leukemias of mature B cells are unknown. Therefore, we examined 170 cases of B-cell chronic lymphocytic leukemia (B-CLL), 7 cases of B-cell prolymphocytic leukemia (B-PLL), 25 cases of h...

2013
Hifzur Rahman Siddique Aijaz Parray Rohinton S. Tarapore Lei Wang Hasan Mukhtar R. Jeffery Karnes Yibin Deng Badrinath R. Konety Mohammad Saleem

For advanced prostate cancer (CaP), the progression of tumors to the state of chemoresistance and paucity of knowledge about the mechanism of chemoresistance are major stumbling blocks in the management of this disease. Here, we provide compelling evidence that BMI1 polycomb group protein and a stem cell factor plays a crucial role in determining the fate of tumors vis-à-vis chemotherapy. We sh...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید